Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine > News > Night-shift work and breast cancer risk: potential biological mechanism identified
  • News

Night-shift work and breast cancer risk: potential biological mechanism identified

  • 6 July 2020
  • Adriana Albini
Night-shift work and breast cancer risk: potential biological mechanism identified
Total
0
Shares
0
0
0
0
0

Is night-shift work a risk factor for breast cancer? Experimental research just published in Nature Communications gives the molecular basis for asserting that it may well be.

Researchers at Paris-Saclay University, with colleagues from Inserm and Inrae, studied the association between night work and increased tumour aggressiveness. They created a simulated jet-lag situation for mice that reproduced a change in the rhythm between day and night. The collaborative teams observed how disturbances in the circadian rhythm had an impact on breast cancer stem cells and the development of breast tumours. In particular they detected an increased spread of cancer cells and the formation of metastases. They speculated that this is related to increased inflammation. The higher expression of chemokines in circadian-disturbed mice induced infiltration of pro-inflammatory myeloid cells in the microenvironment, causing suppression of adaptive immunity.

Several mechanisms have been postulated before to explain an association between night work and breast cancer, with inhibition of the hormone melatonin by the use of artificial light at night widely seen as the most likely (eg Hansen J, Curr Environ Health Rep 2017).
In the study published in Nature Communications, the use of a chemokine receptor inhibitory drug, which influences the neutrophils and myeloid cells, limited the effect on tumour progression, confirming a role for inflammation.

The topic is controversial. In June 2019, a working group convened by the International Agency for Research on Cancer (IARC) concluded that “night shift work” is “probably carcinogenic to humans” (a Group 2A carcinogen). A paper by the Department of Hygiene and Epidemiology of the Medical University of Łódź, Poland, published the following January (Int J Environ Res Public Health, 2020), found a significantly higher risk of cancer among people working at night. However, other studies have found little or no correlation at all. Exactly a year ago (7 July 2020) Lancet Oncology reported a new cohort study concluding that night shift work does not increase the risk of breast cancer.

The evidence from the Nature Communications study provides important additional evidence to support the proposition that such a link does exist, and about the molecular mechanism involved.

Risk factors for breast cancer are multiple: hereditary (mostly BRCA1 and 2 genes), behavioural (smoke, pollution, parity, lactation) or related to poor nutrition or alcohol consumption. Hormonal factors play an obvious role. There is still a long way to go to understand the influence of time-shifts and work-related stress.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • breast cancer
  • circadian rhythms
  • risk factors
  • shift work
Adriana Albini

Adriana Albini is scientific collaborator at the European Institute of Oncology (IEO) in Milan, Professor of General Pathology at the Milan Bicocca University, she has been deputy Chief of Genoa Cancer Center and Head of Research Department of Reggio Emilia Cancer Center and Scientific Director of MultiMedica Onlus.

Previous Article
  • Articles
  • Featured

Guiding career paths from trainee doctor to oncology leader

  • 6 July 2020
  • Anna Wagstaff
View Post
Next Article
  • In the Hot Seat

Solange Peters: ESMO President

  • 6 July 2020
  • Editorial Staff
View Post
You May Also Like
View Post
  • News

CancerWorld #107 (September 2025)

  • Yeva Margaryan
  • 5 September 2025
View Post
  • ESCO Contest
  • News

ESO College Voices Contest 2025: Social media – friend or foe for cancer patients? – Winners Announced

  • Yeva Margaryan
  • 31 August 2025
View Post
  • News

Six Months of CancerWorld Under p53: A Report of Renewal, Responsibility, and Reach

  • Yeva Margaryan
  • 19 August 2025
View Post
  • News

CancerWorld #106 (August 2025)

  • Yeva Margaryan
  • 15 August 2025
View Post
  • Articles
  • Medicine
  • News

Cancer Neuroscience: How Neurons Fuel Tumor Growth, and What it Means for Therapy

  • Sophie Fessl
  • 12 August 2025
View Post
  • News

BRCA1/BRCA2 Mutations Carriers at Greater Risk for Anaplastic Large Cell Lymphoma Associated with Breast Implants

  • Janet Fricker
  • 12 August 2025
View Post
  • News

How a Simple Photo Can Help Predict Survival in Cancer Patients: The FaceAge AI

  • Janet Fricker
  • 12 August 2025
View Post
  • Delivery of Care
  • News
  • Senza categoria

A Bold Step into Building Africa’s Cancer Atlas

  • Esther Nakkazi
  • 22 July 2025
search
CancerWorld #106 Download CancerWorld #105 Download CancerWorld #105 Download CancerWorld #104 Download CancerWorld #103 Download CancerWorld #102 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • CancerWorld #107 (September 2025)
    • 5 September 2025
  • ESO College Voices Contest 2025: Social media – friend or foe for cancer patients? – Winners Announced
    • 31 August 2025
  • Six Months of CancerWorld Under p53: A Report of Renewal, Responsibility, and Reach
    • 19 August 2025
  • CancerWorld #106 (August 2025)
    • 15 August 2025
  • Cancer Neuroscience: How Neurons Fuel Tumor Growth, and What it Means for Therapy
    • 12 August 2025
Article
  • Princess Dina: The Voice for The Voiceless
    • 4 September 2025
  • Patrick Soon-Shiong: He Who Speaks for the People
    • 4 September 2025
  • I Am Alive: Letter to Oncologists
    • 1 September 2025
Social

Would you follow us ?

Contents
  • Princess Dina: The Voice for The Voiceless
    • 4 September 2025
  • Patrick Soon-Shiong: He Who Speaks for the People
    • 4 September 2025
  • I Am Alive: Letter to Oncologists
    • 1 September 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.